Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer
Clinical trial NCT04782089 · UNKNOWN
Trial details
- NCT number
- NCT04782089
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2023-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.